Dingdang Health outlines board composition and committee leadership

Bulletin Express07-21 18:24

On 21 July 2026, Dingdang Health Technology Group Ltd. released an update on its corporate governance structure, confirming the composition of the Board of Directors and the membership of its three standing committees.

The Board now consists of six executive directors—Yang Wenlong (Chairman & President), Yang Yibin, Xu Ning, Yu Qinglong, Meng Fanzhou and Yang Xiao—and three independent non-executive directors—Zhang Shouchuan, Fan Zhenhong and Jiang Shan.

Committee assignments are as follows: • Audit Committee: chaired by independent non-executive director Jiang Shan, with Zhang Shouchuan and Fan Zhenhong as members. • Nomination Committee: chaired by Chairman & President Yang Wenlong and supported by Fan Zhenhong, Zhang Shouchuan, Jiang Shan and Yang Xiao. • Remuneration Committee: chaired by independent non-executive director Fan Zhenhong, with Zhang Shouchuan and Jiang Shan serving alongside.

The announcement confirms that Dingdang Health maintains full compliance with Hong Kong listing requirements for independent oversight, as each committee is led by, or includes, independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114738539?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-21 18:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114738539","market":"us","top_or_hot":-1,"title":"Dingdang Health outlines board composition and committee leadership","media":"Bulletin Express","content":"<p>On 21 July 2026, Dingdang Health Technology Group Ltd. released an update on its corporate governance structure, confirming the composition of the Board of Directors and the membership of its three standing committees.</p>\n<p>The Board now consists of six executive directors—Yang Wenlong (Chairman & President), Yang Yibin, Xu Ning, Yu Qinglong, Meng Fanzhou and Yang Xiao—and three independent non-executive directors—Zhang Shouchuan, Fan Zhenhong and Jiang Shan.</p>\n<p>Committee assignments are as follows:  \n• Audit Committee: chaired by independent non-executive director Jiang Shan, with Zhang Shouchuan and Fan Zhenhong as members.  \n• Nomination Committee: chaired by Chairman & President Yang Wenlong and supported by Fan Zhenhong, Zhang Shouchuan, Jiang Shan and Yang Xiao.  \n• Remuneration Committee: chaired by independent non-executive director Fan Zhenhong, with Zhang Shouchuan and Jiang Shan serving alongside.</p>\n<p>The announcement confirms that Dingdang Health maintains full compliance with Hong Kong listing requirements for independent oversight, as each committee is led by, or includes, independent non-executive directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health outlines board composition and committee leadership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health outlines board composition and committee leadership\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-21 18:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 21 July 2026, Dingdang Health Technology Group Ltd. released an update on its corporate governance structure, confirming the composition of the Board of Directors and the membership of its three standing committees.</p>\n<p>The Board now consists of six executive directors—Yang Wenlong (Chairman & President), Yang Yibin, Xu Ning, Yu Qinglong, Meng Fanzhou and Yang Xiao—and three independent non-executive directors—Zhang Shouchuan, Fan Zhenhong and Jiang Shan.</p>\n<p>Committee assignments are as follows:  \n• Audit Committee: chaired by independent non-executive director Jiang Shan, with Zhang Shouchuan and Fan Zhenhong as members.  \n• Nomination Committee: chaired by Chairman & President Yang Wenlong and supported by Fan Zhenhong, Zhang Shouchuan, Jiang Shan and Yang Xiao.  \n• Remuneration Committee: chaired by independent non-executive director Fan Zhenhong, with Zhang Shouchuan and Jiang Shan serving alongside.</p>\n<p>The announcement confirms that Dingdang Health maintains full compliance with Hong Kong listing requirements for independent oversight, as each committee is led by, or includes, independent non-executive directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1114738539","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114738539","pubTimestamp":1784629456,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 21 July 2026, Dingdang Health Technology Group Ltd. released an update on its corporate governance structure, confirming the composition of the Board of Directors and the membership of its three...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康概述董事会组成和委员会领导层","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"On 21 July 2026, Dingdang Health Technology Group Ltd. released an update on its corporate governance structure, confirming the composition of the Board of Directors and the membership of its three standing committees.\nThe Board now consists of six executive directors—Yang Wenlong (Chairman & President), Yang Yibin, Xu Ning, Yu Qinglong, Meng Fanzhou and Yang Xiao—and three independent non-executive directors—Zhang Shouchuan, Fan Zhenhong and Jiang Shan.\nCommittee assignments are as follows:  \n• Audit Committee: chaired by independent non-executive director Jiang Shan, with Zhang Shouchuan and Fan Zhenhong as members.  \n• Nomination Committee: chaired by Chairman & President Yang Wenlong and supported by Fan Zhenhong, Zhang Shouchuan, Jiang Shan and Yang Xiao.  \n• Remuneration Committee: chaired by independent non-executive director Fan Zhenhong, with Zhang Shouchuan and Jiang Shan serving alongside.\nThe announcement confirms that Dingdang Health maintains full compliance with Hong Kong listing requirements for independent oversight, as each committee is led by, or includes, independent non-executive directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114738539","isCrawlerRequest":true}